Home » Topics » Regulatory

Regulatory
RSS

FDA approves Dymista for use in children with seasonal allergic rhinitis

Feb. 24, 2015

First stem cell-based medicinal product approved in Europe

Feb. 23, 2015

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Feb. 16, 2015

FDA approves lenvatinib for thyroid cancer

Feb. 16, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

FDA grants accelerated approval for Ibrance in advanced breast cancer

Feb. 4, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

FDA approves first drug for Waldenstrom's macroglobulinemia

Feb. 2, 2015

FDA approves Vyvanse for binge eating disorder

Feb. 2, 2015

FDA approves Bristol-Myers Squibb's Evotaz for HIV-1 infection

Jan. 30, 2015

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...